Si W, Li Y, Du G
Front Immunol. 2024; 15:1458231.
PMID: 39430766
PMC: 11486701.
DOI: 10.3389/fimmu.2024.1458231.
Avorio F, Russelli G, Panarello G, Alduino R, Conaldi P, Lo Re V
Front Neurol. 2024; 15:1393104.
PMID: 39026584
PMC: 11254845.
DOI: 10.3389/fneur.2024.1393104.
Yahalom-Ronen Y, Melamed S, Politi B, Erez N, Tamir H, Bar-On L
Vaccines (Basel). 2024; 12(5).
PMID: 38793742
PMC: 11125831.
DOI: 10.3390/vaccines12050491.
Riyaz Tramboo S, Elkhalifa A, Quibtiya S, Ali S, Shah N, Taifa S
Heliyon. 2024; 10(9):e29769.
PMID: 38694122
PMC: 11058722.
DOI: 10.1016/j.heliyon.2024.e29769.
Rajwa B, Naved M, Adibuzzaman M, Grama A, Khan B, Dundar M
PLOS Digit Health. 2024; 3(4):e0000327.
PMID: 38652722
PMC: 11037536.
DOI: 10.1371/journal.pdig.0000327.
Wheel Replacing Pyramid: Better Paradigm Representing Totality of Evidence-Based Medicine.
Aldous C, Dancis B, Dancis J, Oldfield P
Ann Glob Health. 2024; 90(1):17.
PMID: 38435471
PMC: 10906340.
DOI: 10.5334/aogh.4341.
Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landscape and Opportunities.
Leon-Moreno L, Reza-Zaldivar E, Hernandez-Sapiens M, Villafana-Estarron E, Garcia-Martin M, Ojeda-Hernandez D
Biomolecules. 2024; 14(1).
PMID: 38275749
PMC: 10813738.
DOI: 10.3390/biom14010008.
Therapeutic potential and possible mechanisms of ginseng for depression associated with COVID-19.
Zhao F, Zhang K, Chen H, Zhang T, Zhao J, Lv Q
Inflammopharmacology. 2023; 32(1):229-247.
PMID: 38012459
PMC: 10907431.
DOI: 10.1007/s10787-023-01380-0.
An in vitro model of the macrophage-endothelial interface to characterize CAR T-cell induced cytokine storm.
Rosen R, Yang J, Pena J, Schloss R, Yarmush M
Sci Rep. 2023; 13(1):18835.
PMID: 37914765
PMC: 10620221.
DOI: 10.1038/s41598-023-46114-y.
Integrated Transcriptomics and Network Analysis of Potential Mechanisms and Health Effects of Convalescent COVID-19 Patients.
Chujan S, Nakareangrit W, Suriyo T, Satayavivad J
Bioinform Biol Insights. 2023; 17:11779322231206684.
PMID: 37881207
PMC: 10594973.
DOI: 10.1177/11779322231206684.
Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review.
Liu C, Chiu L, Lee C, Chan T
Front Immunol. 2023; 14:1240089.
PMID: 37809102
PMC: 10557068.
DOI: 10.3389/fimmu.2023.1240089.
Neutrophils and the Systemic Inflammatory Response Syndrome (SIRS).
Sikora J, Karawani J, Sobczak J
Int J Mol Sci. 2023; 24(17).
PMID: 37686271
PMC: 10488036.
DOI: 10.3390/ijms241713469.
Treatment of cytokine release syndrome-induced vascular endothelial injury using mesenchymal stem cells.
Wang Y, Dong H, Dong T, Zhao L, Fan W, Zhang Y
Mol Cell Biochem. 2023; 479(5):1149-1164.
PMID: 37392343
DOI: 10.1007/s11010-023-04785-1.
VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants.
Yahalom-Ronen Y, Tamir H, Melamed S, Politi B, Achdout H, Erez N
Viruses. 2023; 15(6).
PMID: 37376662
PMC: 10303402.
DOI: 10.3390/v15061364.
Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review.
Manganotti P, Garascia G, Furlanis G, Buoite Stella A
Front Neurosci. 2023; 17:1159929.
PMID: 37179564
PMC: 10166837.
DOI: 10.3389/fnins.2023.1159929.
Give Them Vasculature and Immune Cells: How to Fill the Gap of Organoids.
Yip S, Wang N, Sugimura R
Cells Tissues Organs. 2023; 212(5):369-382.
PMID: 36716724
PMC: 10711768.
DOI: 10.1159/000529431.
SARS-CoV-2 Infection: What Is Currently Known about Homocysteine Involvement?.
Filip N, Cojocaru E, Badulescu O, Clim A, Pinzariu A, Bordeianu G
Diagnostics (Basel). 2023; 13(1).
PMID: 36611302
PMC: 9818222.
DOI: 10.3390/diagnostics13010010.
Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens.
Morhart P, Kehl S, Schuh W, Hermes K, Meltendorf S, Neubert A
In Vivo. 2023; 37(1):70-78.
PMID: 36593041
PMC: 9843773.
DOI: 10.21873/invivo.13055.
Neuro-Immune Interactions in Severe COVID-19 Infection.
Rossi E, Mutti L, Morrione A, Giordano A
Pathogens. 2022; 11(11).
PMID: 36365007
PMC: 9699641.
DOI: 10.3390/pathogens11111256.
Brain cortical alterations in COVID-19 patients with neurological symptoms.
Sanabria-Diaz G, Etter M, Melie-Garcia L, Lieb J, Psychogios M, Hutter G
Front Neurosci. 2022; 16:992165.
PMID: 36340780
PMC: 9630324.
DOI: 10.3389/fnins.2022.992165.